Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Asymmetric Field Flow Fractionation for Bioreactor Integration
Published on: February 2, 2024
Integrated microfluidic platforms for extracellular vesicles: Separation, detection, and clinical translation
Yang Dai1, Yibo Cui1, Jinwen Li1
1State Key Laboratory of Biobased Material and Green Papermaking, College of Bioengineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong 250353, China.
Integrated microfluidic platforms offer a streamlined approach for separating and detecting extracellular vesicles (EVs). This innovation simplifies complex workflows, accelerating the use of EVs as biomarkers for early disease diagnosis.
Area of Science:
- Biotechnology
- Nanotechnology
- Biomedical Engineering
Background:
- Extracellular vesicles (EVs) are crucial biomarkers for early disease diagnosis, containing proteins and nucleic acids.
- Traditional EV separation and detection methods are complex, time-consuming, and prone to errors, hindering research and clinical application.
- There is a need for integrated platforms that combine multiple EV analysis functions.
Purpose of the Study:
- To review integrated microfluidic platforms for extracellular vesicle (EV) separation and detection.
- To assess the level of integration between separation and detection units in these platforms.
- To highlight the potential of integrated platforms in advancing EV-based diagnostics.
Main Methods:
- Review of recent scientific literature focusing on integrated microfluidic devices for EVs.
- Analysis of platforms based on the full integration of separation and detection modules.
- Examination of studies demonstrating efficient EV separation and high-sensitivity detection.
Main Results:
- Integrated microfluidic platforms simplify workflows, reducing processing time and bioanalyte loss.
- These platforms enable seamless sample-to-result progression for EVs.
- Fully integrated systems show promise for efficient EV separation and sensitive detection.
Conclusions:
- Integrated microfluidic platforms are a promising solution for overcoming current limitations in EV analysis.
- These platforms can accelerate the clinical translation of EVs as biomarkers for diseases like cancer and neurodegenerative disorders.
- Further development of integrated systems will facilitate the routine adoption of EVs in diagnostics.
More Related Videos
06:12Multimodal Analytical Platform on a Multiplexed Surface Plasmon Resonance Imaging Chip for the Analysis of Extracellular Vesicle Subsets
Published on: March 17, 2023
11:32A Microfluidic Platform for Precision Small-volume Sample Processing and Its Use to Size Separate Biological Particles with an Acoustic Microdevice
Published on: November 23, 2015